Abstract
BackgroundPatients with rheumatic diseases (RD) have underlying immune dysregulation and receive long-term immunosuppressive mediations which might negatively affect the outcome of a cancer in those patients. Conversely, autoimmune cells might...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have